A 45-year-old patient with end-stage renal failure undergoes a living-related renal transplant. Which immunosuppressive drug acts by inhibiting the calcineurin pathway to prevent T-cell activation?
- A Azathioprine
- B Mycophenolate mofetil
- C Cyclosporin ✓
- D Sirolimus (Rapamycin)
Explanation
Cyclosporin and tacrolimus are calcineurin inhibitors that block the phosphatase activity of calcineurin, thereby preventing dephosphorylation of NFAT and subsequent transcription of interleukin-2, which is essential for T-cell proliferation. Azathioprine inhibits purine synthesis. Mycophenolate mofetil selectively inhibits inosine monophosphate dehydrogenase in lymphocytes. Sirolimus (mTOR inhibitor) blocks T-cell proliferation downstream of IL-2 signalling without inhibiting calcineurin.
Reference: Bailey & Love's Short Practice of Surgery, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.